Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Glycemic Improvement with a Fixed-dose combination of DPP-4 inhibitor + metformin in patients with Type 2 diabetes (GIFT study) Diabetes Obes
Summary of study design: Schedule and size: Outcomes: Critiques of the study design: Operational and technical challenges: Overall, while the design of the phase 1 study for CT-388 is within standard protocols for new therapeutic agents, certain details of the design and operational aspects would benefit from further clarification
Raid revealed safety failures at a Mochi Health-affiliated pharmacy: According to a King5 report on a March 2025 Washington State Department of Health raid, 503A compounder Aequita Pharmacy illegally imported cheap GLP-1 bulk ingredients to save costs
Bulking Agent (Microcrystalline Cellulose)
US$ 21.27
US$ 27.29
US$ 26.73
US$ 20.41
